We are live on ! Find out more
Bridger Management

Bridger Management Portfolio holdings

AUM $150M Turnover 36.67%
1-Year Est. Return 10.57%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+10.57%
3 Year Est. Return
+101.66%
5 Year Est. Return
+158.29%
10 Year Est. Return
+911%
AUM
$1.48B
AUM Growth
-$64.4M
Cap. Flow
-$200M
Cap. Flow %
-13.49%
Top 10 Hldgs %
48.42%
Holding
44
New
6
Increased
5
Reduced
16
Closed
7
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
1.3 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.9 years

Top Sells

Rank Stock Value
1
MNK
Mallinckrodt
MNK
+$72.1M
2
LH icon
Labcorp
LH
+$57.3M
3
AET
Aetna Inc
AET
+$28.5M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$27.8M
5
CNC icon
Centene
CNC
+$25.6M

Sector Composition

Rank Sector Weight
1 Healthcare 59.89%
2 Consumer Discretionary 10.31%
3 Communication Services 9.2%
4 Industrials 8.19%
5 Consumer Staples 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MGM icon
1
MGM Resorts International
MGM
$8.19B
$103M 6.94%
3,958,970
– –
2015 Q2
5 quarters
BIIB icon
2
Biogen
BIIB
$36.9B
$79.5M 5.36%
254,050
+33,551
+15% +$9.9M
2016 Q2
1 quarter
MDCO
3
DELISTED
Medicines Co
MDCO
$79.2M 5.34%
2,098,000
-314,501
-13% -$11.9M
2014 Q2
9 quarters
WMGI
4
DELISTED
Wright Medical Group
WMGI
$78.3M 5.27%
3,190,076
-789,765
-20% -$18.2M
2015 Q3
4 quarters
POST icon
5
Post Holdings
POST
$3.49B
$78.1M 5.27%
1,012,589
-100,000
-9% -$8.38M
2014 Q4
7 quarters
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$19.3B
$66.6M 4.49%
983,040
+296,031
+43% +$20.9M
2013 Q2
13 quarters
TEVA icon
7
Teva Pharmaceutical Industries
TEVA
$45.8B
$62.5M 4.21%
1,358,287
+53,715
+4% +$2.8M
2015 Q3
4 quarters
IRWD icon
8
Ironwood Pharmaceuticals
IRWD
$778M
$62.3M 4.2%
3,924,333
-1,993,330
-34% -$27.8M
2015 Q1
6 quarters
HUM icon
9
Humana
HUM
$46.8B
$55.1M 3.71%
+311,235
New +$54M
2016 Q3
0 quarters
META icon
10
Meta Platforms (Facebook)
META
$1.43T
$54M 3.64%
420,598
– –
2013 Q2
13 quarters
CHTR icon
11
Charter Communications
CHTR
$14.7B
$52M 3.5%
192,448
-37,056
-16% -$9.36M
2013 Q2
13 quarters
SHPG
12
DELISTED
Shire
SHPG
$49.1M 3.31%
+253,419
New +$49.4M
2016 Q3
0 quarters
NKTR icon
13
Nektar Therapeutics
NKTR
$1.03B
$48.7M 3.28%
188,842
-51,062
-21% -$13.1M
2015 Q4
3 quarters
DXCM icon
14
DexCom
DXCM
$29.6B
$47.2M 3.18%
2,155,436
-678,144
-24% -$15.1M
2015 Q4
3 quarters
PACB icon
15
Pacific Biosciences
PACB
$509M
$44.5M 3%
4,964,123
-218,116
-4% -$1.82M
2015 Q4
3 quarters
AWI icon
16
Armstrong World Industries
AWI
$6.96B
$42.8M 2.88%
+1,034,642
New +$43.3M
2016 Q3
0 quarters
KSU
17
DELISTED
Kansas City Southern
KSU
$42M 2.83%
449,703
– –
2015 Q4
3 quarters
TGTX icon
18
TG Therapeutics
TGTX
$9.6B
$40.3M 2.71%
5,204,618
– –
2013 Q3
12 quarters
GRUB
19
DELISTED
Just Eat Takeaway.com
GRUB
$36.8M 2.48%
428,018
-325,582
-43% -$24.4M
2015 Q3
4 quarters
LBRDA icon
20
DELISTED
Liberty Broadband Class A
LBRDA
$30.6M 2.06%
435,892
– –
2015 Q2
5 quarters
WCG
21
DELISTED
Wellcare Health Plans
WCG
$27.7M 1.86%
236,292
-137,851
-37% -$15.4M
2015 Q2
5 quarters
LH icon
22
Labcorp
LH
$29.8B
$26.9M 1.81%
195,847
-418,037
-68% -$57.3M
2014 Q1
10 quarters
GILD icon
23
Gilead Sciences
GILD
$206B
$26.9M 1.81%
+339,451
New +$27.6M
2016 Q3
0 quarters
AET
24
DELISTED
Aetna Inc
AET
$26.5M 1.79%
229,683
-243,416
-51% -$28.5M
2015 Q3
4 quarters
CNC icon
25
Centene
CNC
$31.6B
$26.2M 1.76%
782,030
-738,360
-49% -$25.6M
2014 Q3
8 quarters

Similar funds

Bridger Management's Q3 2016 Portfolio in Review

As of Q3 2016, Bridger Management held 44 positions worth $1.48B, down 4.2% from $1.55B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Bridger Management withdrew a net $200M in Q3 2016, closing 7 positions and reducing 16 holdings. Its most notable exit was Mallinckrodt, an estimated $72.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 61% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Bridger Management opened a new position in Humana worth $55.1M.

  • Bridger Management's largest Q3 2016 buy was Humana: 311,235 shares worth $55.1M.
  • Bridger Management added most to Alnylam Pharmaceuticals in Q3 2016, an estimated $20.9M increase.
  • Bridger Management's biggest Q3 2016 reduction was Labcorp, cutting an estimated $57.3M.
  • Bridger Management fully exited Mallinckrodt in Q3 2016, selling an estimated $72.1M.
  • Bridger Management's ten largest holdings make up 48% of its $1.48B portfolio in Q3 2016.
  • Bridger Management opened 6 new positions and closed 7 in Q3 2016.
  • Bridger Management's portfolio value fell 4.2% quarter-over-quarter to $1.48B.

Based on Bridger Management's 13F filing for Q3 2016, filed 14 Nov 2016.